Anti-A1BG/ A1B/ ABG functional antibody

Anti-A1BG/ A1B/ ABG functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to A1BG/A1BG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0630-Ab-1/ GM-Tg-hg-SE0630-Ab-2Anti-Human A1BG monoclonal antibodyHuman
GM-Tg-rg-SE0630-Ab-1/ GM-Tg-rg-SE0630-Ab-2Anti-Rat A1BG monoclonal antibodyRat
GM-Tg-mg-SE0630-Ab-1/ GM-Tg-mg-SE0630-Ab-2Anti-Mouse A1BG monoclonal antibodyMouse
GM-Tg-cynog-SE0630-Ab-1/ GM-Tg-cynog-SE0630-Ab-2Anti-Cynomolgus/ Rhesus macaque A1BG monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0630-Ab-1/ GM-Tg-felg-SE0630-Ab-2Anti-Feline A1BG monoclonal antibodyFeline
GM-Tg-cang-SE0630-Ab-1/ GM-Tg-cang-SE0630-Ab-2Anti-Canine A1BG monoclonal antibodyCanine
GM-Tg-bovg-SE0630-Ab-1/ GM-Tg-bovg-SE0630-Ab-2Anti-Bovine A1BG monoclonal antibodyBovine
GM-Tg-equg-SE0630-Ab-1/ GM-Tg-equg-SE0630-Ab-2Anti-Equine A1BG monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0630-Ab-1/ GM-Tg-hg-SE0630-Ab-2; GM-Tg-rg-SE0630-Ab-1/ GM-Tg-rg-SE0630-Ab-2;
GM-Tg-mg-SE0630-Ab-1/ GM-Tg-mg-SE0630-Ab-2; GM-Tg-cynog-SE0630-Ab-1/ GM-Tg-cynog-SE0630-Ab-2;
GM-Tg-felg-SE0630-Ab-1/ GM-Tg-felg-SE0630-Ab-2; GM-Tg-cang-SE0630-Ab-1/ GM-Tg-cang-SE0630-Ab-2;
GM-Tg-bovg-SE0630-Ab-1/ GM-Tg-bovg-SE0630-Ab-2; GM-Tg-equg-SE0630-Ab-1/ GM-Tg-equg-SE0630-Ab-2
Products NameAnti-A1BG monoclonal antibody
Formatmab
Target NameA1BG
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-A1BG benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0630-Ag-1Recombinant multi-species A1BG/ A1B/ ABG protein


    Target information

    Target IDGM-SE0630
    Target NameA1BG
    Gene ID1,117586,712737,484230,101089972,518955,100064369
    Gene Symbol and SynonymsA1B,A1BG,ABG,C44,GAB,HYST2477
    Uniprot AccessionP04217,Q2KJF1,P39091
    Uniprot Entry NameA1BG_HUMAN,A1BG_BOVIN,A1BG_HORSE
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseLung cancer, Type 1 diabetes mellitus, Diabetic Nephropathy, IgA glomerulonephritis, Nephrotic syndrome, Malignant neoplasm of bladder
    Gene EnsemblENSG00000121410
    Target ClassificationN/A

    The target: A1BG, gene name: A1BG, also named as A1B, ABG, GAB, HYST2477. The protein encoded by this gene is a plasma glycoprotein of unknown function. The protein shows sequence similarity to the variable regions of some immunoglobulin supergene family member proteins. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.